PB1935: CARDIOTOXICITY AND SAFETY OF BRUTON’S TYROSINE KINASE INHIBITORS: A REVIEW OF REAL-WORLD OBSERVATIONAL EVIDENCE

• Chakrapani Balijepalli,
• Gaye Siliman,
• Juhi Joshy,
• Lakshmi Gullapalli,
• Eric Druyts

Affiliations

Chakrapani Balijepalli

1 Pharmalytics Group, Vancouver, Canada

Gaye Siliman

1 Pharmalytics Group, Vancouver, Canada

Juhi Joshy

1 Pharmalytics Group, Vancouver, Canada

Lakshmi Gullapalli

1 Pharmalytics Group, Vancouver, Canada

Eric Druyts

1 Pharmalytics Group, Vancouver, Canada